FDA
approval
· 2023-08-21
FDA Approved: VENLAFAXINE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
Summary
FDA approves a supplemental application for Venlafaxine from Sun Pharmaceutical Industries, Inc., updating the generic product under ANDA 078627.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for VENLAFAXINE (VENLAFAXINE)